chrisvoncsefalvay/vaers-outcomes huggingface dataset:
FAST HEARTBEAT; BODY ACHES; MUSCLE CRAMP; SWOLLEN FACE; REALLY COLD; WEAKNESS; SHOOTING PAIN/MUSCLE PAIN; HEADACHE; FEVER/SHIVERS; This spontaneous report received from a patient concerned a 43 year old female. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1805022 expiry: 25/MAY/2021) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 08-APR-2021, the subject experienced fast heartbeat. On 08-APR-2021, the subject experienced body aches. On 08-APR-2021, the subject experienced muscle cramp. On 08-APR-2021, the subject experienced swollen face. On 08-APR-2021, the subject experienced really cold. On 08-APR-2021, the subject experienced weakness. On 08-APR-2021, the subject experienced shooting pain/muscle pain. On 08-APR-2021, the subject experienced headache. On 08-APR-2021, the subject experienced fever/shivers. Treatment medications (dates unspecified) included: acetylsalicylic acid/caffeine/paracetamol/salicylamide, and paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fast heartbeat, and shooting pain/muscle pain on 08-APR-2021, body aches, muscle cramp, and headache on 10-APR-2021, swollen face, and weakness on 11-APR-2021, and really cold, and fever/shivers on 09-APR-2021. This report was non-serious.
Patient noticed next morning the day after receiving vaccine redness,  swelling, warm to touch around injection site and spread down arm but not to elbow. Patient did not take anything for treatment, resolved on its own.
Full body muscle pain Diarrhea Nausea Headache Fatigue (all beginning around 5pm on 10/1/23 and continuing through 10/2/23 at 7pm)
Swelling; redness; itching; if touched it was hot like sunburned and could see like ring around where injection site; bruise; received BNT162B2 (Pfizer-BIONTECH Covid-19 Vaccine,, lot number EL3248, via an unspecified route of administration on 06Jan2021 as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. On 07Jan2021, the patient experienced swelling, redness and itching. On the 3rd day it started going back to normal. just had a bruise like a small bruise for several days up until and last night which would have been a week after and it swelled up, it was very red and if she touched it, it was hot almost like a sunburned and you could see like a perfect ring around where the injection site was. The clinical outcome of the events was not reported,
Due to an administration error, patient received the wrong dose of the Pfizer vaccine.. Patient received the pediatric dose instead of the adult dose for the second dose in the two-dose series.
pt recvd vax, t 103; mom states pt had febrile szs 14AUG94 , to ER,MD dx febrile szs, ear infect; meds given;
This spontaneous report was received from a healthcare worker and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On an unknown date, the patient was vaccinated with an improperly stored dose of VARIVAX lot # M042858, expiration date 21-OCT-2018 (dose and route of administration were not reported). Concomitant therapies included sterile diluent (manufacturer unknown). There was no adverse effect reported. Administered dose of vaccine experienced the temperature excursions of: -14 to -10 degrees Celsius for 3 hours and 45 minutes; -9 to 8 degrees Celsius for 3 hours and 30 minutes. There were no previous excursions reported. Data logger was involved. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513 1705USA008347.
Body ache; Headache; Shivering; This case was reported by a consumer via interactive digital media and described the occurrence of general body pain in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 16th August 2021, the patient received Shingrix. In August 2021, less than a week after receiving Shingrix, the patient experienced general body pain, headache and shivering. On an unknown date, the outcome of the general body pain, headache and shivering were not recovered/not resolved.   It was unknown if the reporter considered the general body pain, headache and shivering to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The patient was experiencing body ache, headache, shivering and no fever at the time of reporting.
acute onset Small Fiber Neuropathy, Disautonomia, Postural Orthostatic Tachycardia Syndrome, Gastroparesis (from SFN)
Developed tightness in arm and neck same night vaccine was given.  Pain then became severe. Neck pain overall in middle but more to left side.  Neck felt "unstable" at one point, same night.  Symptoms improved with NSAIDS and RX muscle relaxant.
Achy; Very cold; Tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Achy), FEELING COLD (Very cold) and FATIGUE (Tired) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (Achy), FEELING COLD (Very cold) and FATIGUE (Tired). At the time of the report, PAIN (Achy), FEELING COLD (Very cold) and FATIGUE (Tired) outcome was unknown.            no concomitant or treatment information was provided.
This spontaneous report as received from a certified medical assistant refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 05-JAN-2016, the patient was vaccinated with an improperly stored dose of RECOMBIVAX HB, lot # K018180, expiration date 17-SEP-2016 (dose and route of administration were not reported). There was no adverse effect reported. Administered dose of vaccine experienced the temperature excursion of 33 degrees Fahrenheit for 13 hours and 47 degrees Fahrenheit for 13 hours. This is one of several reports received from the same reporter. Additional information has been requested.
My husband got a little swelling at the injection site; This spontaneous case was reported by a patient family member or friend and describes the occurrence of VACCINATION SITE SWELLING (My husband got a little swelling at the injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    On 05-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2022, the patient experienced VACCINATION SITE SWELLING (My husband got a little swelling at the injection site). At the time of the report, VACCINATION SITE SWELLING (My husband got a little swelling at the injection site) outcome was unknown.            No Concomitant medications were provided. No treatment medications were provided.
Pt did not respond to Engerix-B vax sereis; 6FEB92 neg HBSAB; Booster dose given;
Persistent Swollen tight uncomfortable throat, initially a  burning sensation ~ 12 hours, difficulty swallowing cleocin cap and foods,  dry cough  This is my second day with symptoms
Approximately 3 to 4 minutes after receiving vaccine, patient stated she was not feeling good and patient turned red and fainted.  She was sitting in chair so mom stood behind her with an ice pack behind neck and holding patient head while dad stood in front of patient.  Her body became limp and mom was shaking her body on right side in attempt to wake patient up.  Her eyes opened but was still unresponsive and she was breathing heavily for 30-40 seconds.  After placing  patient on floor and elevating her legs, patient stated she felt better but still fills nauseated.  Paramedics were called.
Red swollen eyes 4 hrs after shot. Also have a slight fever and sore throat. Eyes have a yellow discharge and are itchy.
no adverse event; expired vaccine used; This spontaneous report has been received from a nurse concerning to a patient of unknown age and gender.  The patient's concurrent conditions, medical history and concomitant medications were not provided.  On an unspecified date in 2021, the patient was vaccinated with an expired dose of Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) 2 ml administered orally (lot#: 1684154, expiration date: 24-JUN-2021) for prophylaxis (expired product administered). No additional adverse events were reported.
other zoster related injuries; shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown age and gender. Information on the patient's concurrent conditions, medical history or concomitant therapy was not reported.   On or about 17-DEC-2013, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, route of administration and anatomical location were not reported), for the long-term prevention of herpes zoster or shingles.         Subsequently, on an unknown date, the patient was treated for shingles and other zoster-related injuries. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), patient has and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; significant medical and related expenses as a result of these injuries, including but not limited to costs for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages. The outcome of the events was unknown. The reporter considered the events to be related to zoster vaccine live (ZOSTAVAX).
10-31-07 Employee declined to get Influenza vaccine, says she has had joint pain x 2 wks, that it is worse in her knees. Said she would let me know if it did not resolve. 1-11-08 pt reports only has burning pain in her knees and it is worse at night. Referred to MD.
Both of the patients legs were red and swollen, she has been crying since she received her immunizations. Brought in by HD at 4:30 instructed to see a doctor. the patient went to P&S for evaluation.
Mom states pt was covered in hives day following inject; pt checked @ clinic & sent to hosp;
Two days after shot had throbbing pains in arm and 4 days later  it got worse and started to travel to left side. through my left arm, spinal cord, left side and shoulder blade.  went on for a little over two and half weeks. so severe i had to miss work.  the last thing i had vibration in left arm like it went to sleep and started to wake up. have been dealing with this since then. it happens randomly through out the day. Still have pain in the upper arm and cant lay on my left arm for more then a few minutes. and it is swollen at the injection site
pain in heart; rash; headache; This spontaneous case was reported by a patient family member or friend and describes the occurrence of CHEST PAIN (pain in heart), RASH (rash) and HEADACHE (headache) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (pain in heart), RASH (rash) and HEADACHE (headache). At the time of the report, CHEST PAIN (pain in heart), RASH (rash) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided
his arm was sore a little bit / little bit of a sore arm; muscle and joint pain; muscle pain / complains of muscle pain to right knee / muscle and joint pain / still have muscle pain after the vaccine; This is a spontaneous report from a contactable consumer (patient). A 36-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number, NDC number and expiry date was not provided) via an unspecified route of administration on 20Jun2021 in right arm as a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date of 2021, the patient experienced little bit of a sore arm for couple of days, and he had muscle pain to right knee and joint pain. He reported no fever or injection site redness. He called to find out if muscle pain was a side effect of the Pfizer covid vaccine. The outcome of the event pain in arm was recovered in 2021 and for other events was unknown.  Information on Lot/Batch information has been requested.
One red raised blister on back of R arm; 2 red, raised blisters on R & L chest this am.  sizes?? diarrhea - am
Patient began with itching and "hives" 24 hours after getting vaccine.  Also reports new blanket on bed.  Taking over the counter Benadryl and Alavert.  States not severe enough to be seen by PCP.
This spontaneous report was received from a registered nurse via company representative refers to a patient of unknown age and gender. No pertinent medical history was reported. On 23-SEP-2015, the patient was vaccinated with expired dose of ZOSTAVAX VIAL (lot # K008882 and expiration date 20-SEP-2015). No adverse effects were reported. Additional information has been requested.
tested positive for covid on 07Aug2022; Lack of drug effect; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (tested positive for covid on 07Aug2022) and DRUG INEFFECTIVE (Lack of drug effect) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 018B21A, 018B21A and 048A21A) for COVID-19 vaccination.  Concurrent medical conditions included Drug allergy (Gabapentin), Allergy to NSAIDs (NSAIDS) and Multiple myeloma since 2019.  On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 12-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Aug-2022, the patient experienced COVID-19 (tested positive for covid on 07Aug2022) and DRUG INEFFECTIVE (Lack of drug effect). At the time of the report, COVID-19 (tested positive for covid on 07Aug2022) and DRUG INEFFECTIVE (Lack of drug effect) outcome was unknown.  DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Aug-2022, SARS-CoV-2 test: (Positive) Positive.  No concomitant medications were reported. No other vaccines were received by the patient within 1 month prior to Moderna COVID-19 vaccine. It was reported that patient was treated with infusion in the ER on 09-Aug-2022.  Company Comment: This is a Spontaneous case concerning 66-year-old female patient with no previous medical history reported, who experienced the non-serious unexpected AESI of COVID-19. The event occurred approximately 8 months after the third dose of mRNA-1273. Doses 1 and 2 of mRNA-1273 were administered in an appropriate schedule of vaccination (28 days between doses). Lack of Efficacy was also noted in this case. It was reported that patient was treated with infusion in the ER. The benefit-risk relationship of COVID-19 Vaccine Moderna (mRNA-1273) is not affected by this report.; Sender's Comments: This is a Spontaneous case concerning 66-year-old female patient with no previous medical history reported, who experienced the non-serious unexpected AESI of COVID-19. The event occurred approximately 8 months after the third dose of mRNA-1273. Doses 1 and 2 of mRNA-1273 were administered in an appropriate schedule of vaccination (28 days between doses). Lack of Efficacy was also noted in this case. It was reported that patient was treated with infusion in the ER. The benefit-risk relationship of COVID-19 Vaccine Moderna (mRNA-1273) is not affected by this report.
started after shot #2 , server head ache, sore throat chills sweats, fatigued was in bed for three days. I still have a sore throat. As of 3/18/2021
Patient said he felt fine following administration of the vaccine. He said that when he went home and slept and then woke up, he said he was having trouble gripping with his left hand, and that when he massaged it, it felt tingly. He said he was going to the ER to have it checked out. I asked him to call me to update so I could submit to VAERS. I followed up several times, finally reaching him on 7/27/17. He had an appointment with the doctor the next day who said it could take a couple weeks for the symptoms to go away. But he did say the severity of his symptoms was getting better. On 8/8/17, per a conversation with the doctor's office, patient had received a TDaP vaccine already on 7/16/17 (although patient reported on his consent form that he had not had any vaccinations or skin tests in the past 4 weeks). When I asked for a diagnosis, they did not have a specific diagnosis and their information about which arm was affected was conflicting. I called the patient several days without being able to reach him, but on 8/24/17 he came into the pharmacy and confirmed it was his left arm. He said his symptoms were much better.
Pt c/o itchy arms, head, neck and chest. Red hives visible. Voice sounded scratchy. No SOB and V.S. stable x 3. Husband called to bring own meds. Took 25 mg/BENADRYL P.O. from own purse and another 25 mg BENADRYL when husband arrived. Dr. advised pt. via phone to also use her own inhaler x 2. *Refused EPIPEN and BENADRYL IM protocol x 3. Wanted to go home with husband. Symptoms all decreasing when she left at 4:20. Patient followed orders from her own physician by phone. Refused our protocol.
after a few days i had Little bit of pain in my shoulder, and muscle pain, nausea, headache. over all not feeling well.
Shingles.  Treated with Valtrex.  Multiple sites but mostly on right chest and arm.
ill; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (ill) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (ill). At the time of the report, ILLNESS (ill) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.
This spontaneous report as received from a healthcare worker refers to a patient of an unknown age and gender. The patient's relevant medical history, concurrent conditions and concomitant medications were not reported. On an unknown date on or after 02-NOV-2015, the patient was vaccinated with improperly stored dose of PNEUMOVAX 23 (lot # L019835 and expiry date: 23-MAR-2017) at an unknown dosage. Excursion details included: temperature 27 F and no previous temperature excursion, time frame was 6 weeks (42 days) and was because of data logger. No adverse effect reported. It was reported that the M-M-R II appears in the product list as it was involved in the excursion, however no improperly stored doses of M-M-R II were administered. Additional information has been requested.
SHOT KILLED; This spontaneous report received from a consumer via social media concerned a patient of unspecified age, sex, race and ethnic origin. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) frequency 1 total, dose  (dose number series 1), start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the consumer stated "shot killed my loved one" (death). On an unspecified date, the patient died from unknown cause. It was unspecified if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).; Sender's Comments: V0: 20211164482-COVID-19 VACCINE AD26.COV2.S-shot killed. This event(s) is considered unassessable. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH
11/01/21 presents to ED with "left shoulder pain".  PMH of "CAD/stenting, HTN, DM type 2".  Pt was "diagnosed with COVID-19 on 10/11/21 and received Bamlanivimab infusion on 10/13/21" at hospital.
pt recv vax & 2-3 days post vax pt devel a raised itchy rash on the lt side of abd;the rash lasted 2wk, faded, & then came back 1wk later;tx topical hydrocortisone & backbone spray;
On April 13th I started heavy vaginal bleeding and have continued to bleed heavily to date.  I had my period the week prior so it is not my regular period,
Redness and swelling right upper arm starting 1 day after receiving DTAP and MMR.
After IM injection pt had some discomfort in arm and site which progressed as day went on with decreased ROM due to pain where was more at shoulder to deltoid pain with movement and at rest. Used heat/ice ibuprofen and pain continued, no redness or swelling at site. Over 1 week decreased symptoms but still 3/10 office visit has decreased symptoms time of visit
I feel that it was encephalopathy. I had a 2 degree increase in temperature, was confused, forgetful, felt hot and dry, sensitive to light, weak, muscle aches and blurred vision. My head felt full like my brain was swollen. These lasted 1 week. I had sinusitis 11 days after onset and I still have rhinitis. Per doc 213152, patient temp is 97o,+ for a week, then was 99o from 12/17/2001 to 12/24/2001. Then was above normal for another month. Patient got a nasal infection. Report also states that encephalopathy occurred 5 days after the flu injection. Patient also has dry nose which cause bleeding.
Initial report received on 03 March 2008 from a health care professional.  A 23-year-old male patient had received a first dose, left deltoid, intramuscular injection of MENACTRA, lot number U2558AA, on 11 February 2008; and a first dose, left deltoid, intramuscular injection of PNEUMOVAX, manufacturer Merck, lot number 0380U, on 29 February 2008.  Eighteen days following vaccination with MENACTRA and three hours following vaccination with PNEUMOVAX, the patient developed numbness from the left forearm to fingers, swelling of the left elbow, and swelling to the left upper arm.  The event did not require medical examination, and diagnostic testing was none.  The swelling of the left upper arm resolved, but swelling to the left elbow remained.  At the time of this report, the patient had not recovered.